IRCT20200330046899N1招募中3 期
Evaluating the efficacy of herbal capsule in COVID-19 patients in a clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients who require hospitalization based on national guidelines for diagnosis and treatment of COVID-19 and need to start drugs.
- •18 to 75 years of age for both sexes
- •The patient's ability to fill out an informed consent form to enter the study
排除标准
- •Pregnancy and lactation
- •History of allergy to any of the components of the herbal product
- •The patient's inability to take oral form
- •The patients with serious underlying disease at the same time, including high blood pressure, heart disease, lung disease, cerebral disease, diabetes.
研究者
相似试验
尚未招募
2 期
Herbal preparation for the treatment of COVID-19: Randomized clinical trial to test the safety and efficacy on the viral clearance of SARS-CoV-2PACTR202210816121866Faculty of Pharmacy120
已完成
2 期
Evaluating the effect of herbal supplement capsule on treatment of peptic disease patientsGastric ulcerIRCT20151230025772N10Zojaj Darman Toos pharmaceutical company70
招募中
2 期
Study on herbal neutraceuticals in delivering physical energyCTRI/2023/02/049575MVR Ayurveda medical college and hospital
已完成
2 期
A comparative study on the effects of herbal capsule of Melisa and Mefenamic acid on postpartum after paiIRCT201608023860N25Vice chancellor for research of Shahid Beheshti University of Medical Sciences(SBUMS)70
尚未招募
2 期
Clinical evaluation of herbal formulations in adults with acute/chronic pain and inflammatioCTRI/2023/07/055425Plant Ayu Life Sciences LLP Pune